Cannabis for endometriosis-related pain and symptoms : it's high time that we see this as a legitimate treatment

Mike Armour, Justin Sinclair

Research output: Contribution to journalArticlepeer-review

Abstract

Endometriosis is an oestrogen-dependent, chronic inflammatory condition characterised by the presence of endometrial-like tissue outside of the uterus. In Australia, 11% of women and those assigned female at birth have a diagnosis of endometriosis by the age of 44 years.1 Endometriosis-related chronic pelvic pain includes a variety of symptoms such as dysmenorrhoea, dyspareunia, fatigue, dyschezia, and dysuria. Endometriosis places significant burden on patients, their families, and society as a whole. The cost of illness burden in Australia is $30 000 per woman per year, or $9.7B in total, with most costs being due to lost productivity, 2 with pain severity being the most significant modifiable factor. A modest reduction in pain of just 20% would save approximately $9000 per woman per year,2 in addition to improvements in health-related quality of life. Therefore, effective pain management strategies are vital to reduce economic disease burden and improve quality of life.
Original languageEnglish
Pages (from-to)118-120
Number of pages3
JournalAustralian and New Zealand Journal of Obstetrics and Gynaecology
Volume63
Issue number1
DOIs
Publication statusPublished - Feb 2023

Fingerprint

Dive into the research topics of 'Cannabis for endometriosis-related pain and symptoms : it's high time that we see this as a legitimate treatment'. Together they form a unique fingerprint.

Cite this